Wednesday, August 02, 2006

Private vs. Public Health Care and $99,680.00

In the realm of American style health care, operations are revenue generating and are rarely cancelled, in our Canadian system operations are costs that need to be contained.

I am grateful that Pace benefits from the universality of Canadian Health Care. It cost $8,000.00 per treatment of Abraxane and $920.00 per treatment of FEC, totaling $99,680.00 for Pace's chemotherapy drugs alone.

How product managers at any oncological pharmaceutical companies expect the middle class to keep up with these kind of bills is beyond me.

No comments: